{"id":1068125,"date":"2021-01-20T01:13:31","date_gmt":"2021-01-20T06:13:31","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/rafael-pharmaceuticals-to-present-at-b-riley-securities-virtual-oncology-investor-conference\/"},"modified":"2024-08-18T11:43:10","modified_gmt":"2024-08-18T15:43:10","slug":"rafael-pharmaceuticals-to-present-at-b-riley-securities-virtual-oncology-investor-conference","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/rafael-pharmaceuticals-to-present-at-b-riley-securities-virtual-oncology-investor-conference.php","title":{"rendered":"Rafael Pharmaceuticals to Present at B. Riley Securities Virtual Oncology Investor Conference"},"content":{"rendered":"<p><![CDATA[President and CEO Sanjeev Luther and Co-Chief Medical Officer Tim Pardee, M.D., Ph.D., will discuss clinical trial launches, FDA-granted Fast Track designations and other recent accomplishments on Wednesday, Jan. 20 President and CEO Sanjeev Luther and Co-Chief Medical Officer Tim Pardee, M.D., Ph.D., will discuss clinical trial launches, FDA-granted Fast Track designations and other recent accomplishments on Wednesday, Jan. 20]]><\/p>\n<p>Read this article:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2021\/01\/19\/2160903\/0\/en\/Rafael-Pharmaceuticals-to-Present-at-B-Riley-Securities-Virtual-Oncology-Investor-Conference.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Rafael Pharmaceuticals to Present at B. Riley Securities Virtual Oncology Investor Conference\">Rafael Pharmaceuticals to Present at B. Riley Securities Virtual Oncology Investor Conference<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read this article: Rafael Pharmaceuticals to Present at B. Riley Securities Virtual Oncology Investor Conference <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/rafael-pharmaceuticals-to-present-at-b-riley-securities-virtual-oncology-investor-conference.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068125","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068125"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068125"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068125\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068125"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068125"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068125"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}